Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a ‘Real-Life’ Study

Ninety-four adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) were treated with fractionated doses of gemtuzumab ozogamicin (GO) at one-single French center over ten years. We attempted to define predictive factors for response and survival. The overall response rate wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurino, Marica, Loron, Sandrine, Larcher, Marie-Virginie, Fossard, Gaëlle, Elhamri, Mohamed, Deloire, Alexandre, Balsat, Marie, Barraco, Fiorenza, Labussière, Hélène, Ducastelle, Sophie, Renault, Myriam, Wattel, Eric, Heiblig, Maël, Salles, Gilles, Thomas, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202336/
https://www.ncbi.nlm.nih.gov/pubmed/32395209
http://dx.doi.org/10.4084/MJHID.2020.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202336/
https://www.ncbi.nlm.nih.gov/pubmed/32395209
http://dx.doi.org/10.4084/MJHID.2020.020

Ejemplares similares